Clinical Cancer Research CR Surrogrates AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurahara, H.
Right arrow Articles by Aikou, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurahara, H.
Right arrow Articles by Aikou, T.
Clinical Cancer Research Vol. 10, 8413-8420, December 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Impact of Vascular Endothelial Growth Factor-C and -D Expression in Human Pancreatic Cancer

Its Relationship to Lymph Node Metastasis

Hiroshi Kurahara, Sonshin Takao, Kousei Maemura, Hiroyuki Shinchi, Shoji Natsugoe and Takashi Aikou

Division of Surgical Oncology, Department of Oncology and Research Center for Life Science Resources, Kagoshima University Faculty of Medicine, Kagoshima, Japan

Purpose: The aim of this study was to evaluate the expression of vascular endothelial growth factor (VEGF)-C and -D in pancreatic cancer and to reveal its relation to lymph node metastasis.

Experimental Design: Formalin-fixed, paraffin-embedded blocks were obtained from 58 patients with pancreatic head cancer. All of the patients underwent a curative resection. The total number of resected lymph nodes was 1,058. The expressions of VEGF-C and -D were evaluated by immunohistochemical staining. To evaluate the relation to lymph node metastasis, the expressions of VEGF-C and -D between the marginal and central portions in the tumor were compared. When >25% of the tumor cells showed distinct staining, the portion was judged as high expression.

Results: The two groups with high expression of VEGF-C (P = 0.015) and VEGF-D (P = 0.020) in the marginal portion had a significantly higher incidence of lymph node metastasis compared with the groups with low expression, respectively. Furthermore, the group with high expression of both VEGF-C and -D in the marginal portion had a higher incidence of lymph node metastasis compared with the group with low expression (P = 0.007). The 5-year survival rate of patients with high expression of both VEGF-C and -D in the marginal portion was significantly lower than that of patients with low expression of both VEGF-C and -D (P = 0.017).

Conclusions: VEGF-C and -D expression in tumor cells in the marginal portion of the tumor significantly associated with lymphatic metastasis and prognosis in patients with pancreatic head cancer.




This article has been cited by other articles:


Home page
Am J Clin PatholHome page
R. S. Saad, J. L. Lindner, Y. Liu, and J. F. Silverman
Lymphangiogenesis in Esophageal Adenocarcinomas--Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma
Am J Clin Pathol, January 1, 2009; 131(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Kopfstein, T. Veikkola, V. G. Djonov, V. Baeriswyl, T. Schomber, K. Strittmatter, S. A. Stacker, M. G. Achen, K. Alitalo, and G. Christofori
Distinct Roles of Vascular Endothelial Growth Factor-D in Lymphangiogenesis and Metastasis
Am. J. Pathol., April 1, 2007; 170(4): 1348 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho
Genetics and biology of pancreatic ductal adenocarcinoma.
Genes & Dev., May 15, 2006; 20(10): 1218 - 1249.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Miyata, S. Kanda, K. Ohba, K. Nomata, Y. Hayashida, J. Eguchi, T. Hayashi, and H. Kanetake
Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D
Clin. Cancer Res., February 1, 2006; 12(3): 800 - 806.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Gombos, X. Xu, C. S. Chu, P. J. Zhang, and G. Acs
Peritumoral Lymphatic Vessel Density and Vascular Endothelial Growth Factor C Expression in Early-Stage Squamous Cell Carcinoma of the Uterine Cervix
Clin. Cancer Res., December 1, 2005; 11(23): 8364 - 8371.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Santini, B. Vincenzi, G. Perrone, C. Rabitti, D. Borzomati, S. Valeri, R. Coppola, P. Magistrelli, and G. Tonini
Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma
Ann. Onc., November 1, 2005; 16(11): 1847 - 1848.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.